Thalidomide Administration for the Treatment of Resistant Plasma Cell Leukemia

Publisher： Karger

E-ISSN： 1421-9662|109|3|153-155

ISSN： 0001-5792

Source： Acta Haematologica, Vol.109, Iss.3, 2003-05, pp. : 153-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Novel Agents for the Treatment of Primary Plasma-Cell Leukemia: Lights and Shadows

By  

Acta Haematologica, Vol. 135, Iss. 2, 2016-0 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Lymphoplasmacytoid cytology in plasma cell leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 460-461

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination therapy incorporating Bcl‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 2018-02 ,pp. : 215-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two Cases of Plasma Cell Leukemia with Atypical Immunophenotype

By  

Acta Haematologica, Vol. 118, Iss. 1, 2007-04 ,pp. : 27-29

Karger

Access to resources Recommend Favorite

Significantly Better Prognosis for Patients with Primary Plasma Cell Leukemia than for Patients with Secondary Plasma Cell Leukemia

By  

Acta Haematologica, Vol. 118, Iss. 3, 2007-10 ,pp. : 178-182

Karger

Access to resources Recommend Favorite